Search Results - "Denaxas, Konstantinos"

Mo1505 - Association Between Scleroderma Esophagus and Systemic Sclerosis Manifestations by Karamanolis, Georgios, Denaxas, Konstantinos, Kamberoglou, Dimitrios, Papatheodoridis, George

Get full text

Association Between Scleroderma Esophagus and Systemic Sclerosis Manifestations by Karamanolis, Georgios, Denaxas, Konstantinos, Kamberoglou, Dimitrios, Papatheodoridis, George

Get full text

Evaluation and management of esophageal manifestations in systemic sclerosis by Denaxas, Konstantinos, Ladas, Spyros D, Karamanolis, George P

“…Systemic sclerosis (SSc) is a multisystemic autoimmune connective tissue disorder; in the gastrointestinal tract, the esophagus is the most commonly affected…”
Get full text

The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial by Karamanolis, George P, Panopoulos, Stylianos, Denaxas, Konstantinos, Karlaftis, Anastasios, Zorbala, Alexandra, Kamberoglou, Dimitrios, Ladas, Spiros D, Sfikakis, Petros P

“…Acute administration of the oral 5-HT1A receptor agonist buspirone, which is commonly used as an anxiolytic drug, may improve compromised lower esophageal…”
Get full text

Mo1512 - Treatment of Functional Chest Pain: Citalopram, Amitriptylin or no Treatment by Karamanolis, Georgios, Katopodi, Konstantina, Denaxas, Konstantinos, Kamberoglou, Dimitrios, Viazis, Nikos, Papatheodoridis, George, Vlachogiannakos, John

Get full text

Tu1411 Beneficial Effect of Long-Term Buspirone Administration on LES Function and on Esophageal Symptoms in Patients With Systemic Sclerosis by Karamanolis, George, Denaxas, Konstantinos, Karlaftis, Anastasios, Kamberoglou, Dimitrios, Papatheodoridis, George V, Ladas, Spiros D

Get full text

Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain by Viazis, Nikos, Katopodi, Konstantina, Karamanolis, George, Denaxas, Konstantinos, Varytimiadis, Lazaros, Galanopoulos, Michail, Tsoukali, Emmanouela, Kamberoglou, Dimitirs, Christidou, Angeliki, Karamanolis, Dimitrios G, Papatheodoridis, George, Mantzaris, Gerasimos J

“…INTRODUCTIONAlthough gastroesophageal reflux disease is the main cause of noncardiac chest pain (NCCP), proton pump inhibitors (PPIs) benefit a minority of…”
Get full text

Severe oesophageal disease and its associations with systemic sclerosis by Karamanolis, Georgios P, Denaxas, Konstantinos, Panopoulos, Stylianos, Bournia, Kalliopi-Vasiliki, Zorbala, Alexandra, Kamberoglou, Dimitrios, Schizas, Dimitrios, Ladas, Spiros D, Sfikakis, Petros P

“…Severe oesophageal disease in patients with systemic sclerosis (SSc), referred as scleroderma oesophagus, is characterised by ineffective or absent peristalsis…”
Get full text

Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study by Karamanolis, George P, Panopoulos, Stylianos, Karlaftis, Anastasios, Denaxas, Konstantinos, Kamberoglou, Dimitrios, Sfikakis, Petros P, Ladas, Spiros D

“…Background Esophageal involvement in systemic sclerosis (SSc) carries significant morbidity and is empirically managed with domperidone, albeit with…”
Get full text

Beneficial effect of the 5‐HT 1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study by Karamanolis, George P, Panopoulos, Stylianos, Karlaftis, Anastasios, Denaxas, Konstantinos, Kamberoglou, Dimitrios, Sfikakis, Petros P, Ladas, Spiros D

“…Background Esophageal involvement in systemic sclerosis (SSc) carries significant morbidity and is empirically managed with domperidone, albeit with…”
Get full text